Tag: Side Effects
Thrombosis, Thrombocytopenia Syndrome Up After Ad26.COV2.S
Reporting rates 3.83 per million vaccine doses for Ad26.COV2.S versus 0.00855 per million for mRNA-based vaccines
Risk for Carditis Tied to Second Dose of Pfizer-BioNTech COVID-19 Vaccine
No such increased risk seen with Sinovac inactivated virus vaccine
Serious Adverse Effects From COVID-19 Vaccines Reported Rarely
Full vaccination dose, younger age, female sex, and previously having had COVID-19 linked to greater odds of adverse effects
Adverse Events Rare After BNT162b2 Vaccine in 5- to 11-Year-Olds
Data show 4,249 reports of adverse events after about 8.7 million doses of vaccine were administered; 97.6 percent not serious
Adverse Events Associated With BNT162b2 Vaccination ID’d
Vaccination not associated with elevated risk for most of the adverse events examined; association found with increased risk for myocarditis, but risk higher in association with SARS-CoV-2 infection
For U.S. Teens, Most Adverse Events to COVID-19 Vaccine Nonserious
Frequency of local, systemic reactions reported for teens enrolled in v-safe similar to preauthorization clinical trials
Review: Benefit Outweighs Harm of Statins for Primary Prevention of CVD
Risk for adverse events attributable to statins low when used for primary prevention of cardiovascular disease
FDA Adds Guillain-Barré Warning to J&J COVID-19 Vaccine
About 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered
Venous Thromboembolic Event Rates Up With ChAdOx1-S Vaccine
However, absolute risks are small, with 11 excess venous thromboembolic events per 100,000 vaccinations
Systemic Reactogenicity Up With Heterologous COVID-19 Vaccine Doses
More reported feverishness, chills, fatigue, headache, joint pain, malaise, muscle ache after heterologous versus homogenous doses
